Cargando…
Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression
Liver metastasis is a major cause of mortality in colorectal cancer (CRC). The current study was to investigate the ability of ulinastatin (UTI) and curcumin (CUR) to inhibit CRC liver metastases via modulating matrix metalloproteinase-9 (MMP-9) and E-cadherin expression. Human CRC HCT-116 cells wer...
Autores principales: | Shen, Fei, Cai, Wen-Song, Li, Jiang-Lin, Feng, Zhe, Liu, Qi-cai, Xiao, Huan-qing, Cao, Jie, Xu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933719/ https://www.ncbi.nlm.nih.gov/pubmed/24570592 http://dx.doi.org/10.2147/OTT.S57126 |
Ejemplares similares
-
Ulinastatin Reduces Cancer Recurrence after Resection of Hepatic Metastases from Colon Cancer by Inhibiting MMP-9 Activation via the Antifibrinolytic Pathway
por: Xu, Bo, et al.
Publicado: (2013) -
Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
por: Zeng, Z. S., et al.
Publicado: (1995) -
Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion
por: Hsu, Chih-Chin, et al.
Publicado: (2016) -
Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999) -
Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer
por: Jonsson, Andreas, et al.
Publicado: (2018)